Researchers at UPMC and Penn State have developed a new mRNA vaccine platform that is more scalable and adaptable, offering rapid protection against viruses like COVID-19 and H5N1.
SARS-CoV-2
The results underline the necessity for widespread surveillance as well as the discovery of new SARS-CoV-2 mutations in animals.